Nicola Mikulcik Ohrner
Corporate Officer/Principal bij FORMYCON AG
Actieve functies van Nicola Mikulcik Ohrner
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| FORMYCON AG | Corporate Officer/Principal | 01-06-2022 | - |
bioeq GmbH
 bioeq GmbH Pharmaceuticals: MajorHealth Technology bioeq GmbH develops biosimilar drugs. The company was founded in March 2014 and is headquartered in Holzkirchen, Germany. | Algemeen Directeur | - | - |
Bioeq AG
 Bioeq AG Pharmaceuticals: MajorHealth Technology Bioeq AG operates as a biopharmaceutical company, which licenses, develops and commercializes biological successor products. It offers FYB201, an advanced biosimilar program intended for use in place of existing, branded biologics to treat a range of chronic and often life-threatening diseases. The company is headquartered in Zug, Switzerland. | Directeur/Bestuurslid | - | - |
Loopbaan van Nicola Mikulcik Ohrner
Statistieken
Internationaal
| Duitsland | 3 |
| Zwitserland | 2 |
Operationeel
| Chief Executive Officer | 1 |
| Director/Board Member | 1 |
| Corporate Officer/Principal | 1 |
Sectoraal
| Health Technology | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| FORMYCON AG | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Bioeq AG
Bioeq AG Pharmaceuticals: MajorHealth Technology Bioeq AG operates as a biopharmaceutical company, which licenses, develops and commercializes biological successor products. It offers FYB201, an advanced biosimilar program intended for use in place of existing, branded biologics to treat a range of chronic and often life-threatening diseases. The company is headquartered in Zug, Switzerland. | Health Technology |
bioeq GmbH
bioeq GmbH Pharmaceuticals: MajorHealth Technology bioeq GmbH develops biosimilar drugs. The company was founded in March 2014 and is headquartered in Holzkirchen, Germany. | Health Technology |
